Guys only 1 more day or so, this Friday we will see just how good the self delivering RNAi technology is. IMO this is game changing just like the CEO mentions. We have added 2 new directors Lockshin and Dorman , they wouldn't join the board if the technology wasn't groundbreaking.
By the way we have a very good Chief Scientific Officer Pamela pavco. She has worked with oligonucleotides for 20 years! She even worked for Sirna Therapeutics before it was acquired by Merck for 1.1 billion dollars. We are in good hands here folks technology is good and management is good! Can't believe the value is still at .195 cents or so! RXII deserves a bigger value!
News 
Market Data 
Discover 
AI
